D. Protic, M. Stojkovic, and D. Budimirovic, “TARGETED DRUG DEVELOPMENT IN FRAGILE X SYNDROME: MOLECULAR MEDICINE AS A KEY TOOL IN CLINICAL PHARMACOLOGY”, medi, vol. 59, no. 2, Sep. 2025, doi: 10.5937/medi0-60213.